全国细菌耐药监测网2020—2024年腹腔积液标本细菌耐药监测报告
作者:
作者单位:

作者简介:

通讯作者:

中图分类号:

R181.3+2

基金项目:


Antimicrobial resistance of bacteria from peritoneal effusion specimens: surveillance report from China Antimicrobial Resistance Surveillance System, 2020-2024
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 文章评论
    摘要:

    目的 了解全国细菌耐药监测网(CARSS)成员单位腹腔积液标本病原菌的分布特点及对抗菌药物的耐药性。方法 分析2020年1月1日—2024年12月31日CARSS成员单位腹腔积液标本分离的菌株,依据保留同一患者相同细菌第一株的原则剔除重复菌株后纳入分析,药敏结果判断参照当年美国临床实验室标准化协会(CLSI)推荐的标准。结果 2020—2024年CARSS成员单位临床送检腹腔积液标本共分离细菌373 238株,其中革兰阳性菌占 39.2%,革兰阴性菌占60.8%。分离率位于前10位的细菌分别为大肠埃希菌(30.3%)、肺炎克雷伯菌(9.3%)、屎肠球菌(7.6%)、表皮葡萄球菌(5.4%)、粪肠球菌(5.3%)、铜绿假单胞菌(4.8%)、金黄色葡萄球菌(4.2%)、阴沟肠杆菌(2.5%)、溶血葡萄球菌(2.4%)及鲍曼不动杆菌(2.3%)。金黄色葡萄球菌和凝固酶阴性葡萄球菌中甲氧西林耐药株[耐甲氧西林金黄色葡萄球菌(MRSA)、 耐甲氧西林凝固酶阴性葡萄球菌(MRCNS)]的检出率分别为27.9%~32.1%、70.6%~72.9%,甲氧西林耐药株对绝大多数抗菌药物的耐药率均高于甲氧西林敏感株,未发现对万古霉素和替考拉宁耐药的菌株。肠球菌属中屎肠球菌对多数测试抗菌药物的耐药率高于粪肠球菌:粪肠球菌对万古霉素和替考拉宁的耐药率分别为0.2%~0.4%、0.3%~0.7%;屎肠球菌对替考拉宁的耐药率为0.6%~5.7%,对万古霉素的耐药率为0.7%~4.2%,呈明显增长趋势。耐碳青霉烯酶类的肺炎克雷伯菌、鲍曼不动杆菌和铜绿假单胞菌的检出率分别为11.1%~13.8%、49.1%~56.1%、11.8%~14.4%,均呈现下降趋势。耐碳青霉烯酶类大肠埃希菌检出率为1.9%~2.1%,阴沟肠杆菌对亚胺培南和美罗培南的耐药率分别为5.9%~8.0%、6.2%~8.1%,弗劳地柠檬酸杆菌对亚胺培南和美罗培南的耐药率分别为4.3%~10.9%、3.9%~8.8%,三者呈上升趋势。结论 腹腔积液中临床分离株检出数量呈增长趋势,重点监测耐药菌株检出率多呈现下降趋势,但耐碳青霉烯类大肠埃希菌、耐万古霉素屎肠球菌的检出率增加,阴沟肠杆菌、弗劳地柠檬酸杆菌对碳青霉烯类抗生素的耐药率升高,应密切观察并高度重视,避免其在医院内播散传播。

    Abstract:

    Objective To understand the distribution characteristics and antimicrobial resistance of pathogenic bacteria isolated from peritoneal effusion specimens from member units of China Antimicrobial Resistance Surveillance System (CARSS). Methods Bacterial strains isolated from peritoneal effusion specimens of CARSS member units from January 1, 2020 to December 31, 2024 were analyzed. Repetitive strains of the same bacteria from the same patient were excluded, only the first strain was retained for analysis. Antimicrobial susceptibility testing results were assessed according to the standards of American Clinical and Laboratory Standards Institute (CLSI). Results A total of 373 238 bacterial strains were isolated from peritoneal effusion specimens from CARSS member units in 2020-2024, 39.2% were Gram-positive and 60.8% were Gram-negative strains. The top 10 isolated bacteria were Escherichia coli (30.3%), Klebsiella pneumoniae (9.3%), Enterococcus faecium (7.6%), Staphylococcus epidermidis (5.4%), Enterococcus faecalis (5.3%), Pseudomonas aeruginosa (4.8%), Staphylococcus aureus (4.2%), Enterobacter cloacae (2.6%), Staphylococcus haemolyticus (2.4%), and Acinetobacter baumannii (2.3%). Among Staphylococcus aureus and coagulase negative Staphylococcus, the detection rates of methicillin-resistant strains (methicillin-resistant Staphylococcus aureus [MRSA] and methicillin-resistant coagulase negative Staphylococcus [MRCNS]) were 27.9%-32.1% and 70.6%-72.9%, respectively. Resistance rates of methicillin-resistant strains to most antimicrobial agents were higher than methicillin-sensitive strains, while no strain was found to be resistant to vancomycin and teicoplanin. Among Enterococcus spp., Enterococcus faecium had higher resistance rates to most tested antimicrobial agents than Enterococcus faecalis. The resistance rates of Enterococcus faecalis to vancomycin and teicoplanin were 0.2%-0.4% and 0.3%-0.7%, respectively. The resistance rates of Enterococcus faecium to teicoplanin and vancomycin were 0.6%-5.7% and 0.7%-4.2%, respectively, both showing significant increase trends. The detection rates of carbapenem-resistant Klebsiella pneumoniae, Acinetobacter baumannii, and Pseudomonas aeruginosa were 11.1%-13.8%, 49.1%-56.1% and 11.8%-14.4%, respectively, all showing downward trends. Detection rates of carbapenem-resistant Escherichia coli were 1.9%-2.1%; resistance rates of Enterobacter cloacae to imipenem and meropenem were 5.9%-8.0% and 6.2%-8.1%, respectively; and resistance rates of Citrobacter freundii to imipenem and meropenem were 4.3%-10.9% and 3.9%-8.8%, respectively; all showing upward trends. Conclusion The number of clinical isolates detected from peritoneal effusion presents an increasing trend. Detection rates of most major antimicrobial-resistant strains present decreasing trends, while the detection rates of carbapenem-resistant Escherichia coli and vancomycin-resistant Enterococcus faecium have risen. Resistance rates of Enterobacter cloacae and Citrobacter freundii to carbapenem antibiotics have increased, which should be closely observed and given high priority, so as to avoid the spread within hospital.

    参考文献
    相似文献
引用本文

全国细菌耐药监测网.全国细菌耐药监测网2020—2024年腹腔积液标本细菌耐药监测报告[J]. 中国感染控制杂志,2025,24(12):1735-1745. DOI:10.12138/j. issn.1671-9638.20255417.
China Antimicrobial Resistance Surveillance System. Antimicrobial resistance of bacteria from peritoneal effusion specimens: surveillance report from China Antimicrobial Resistance Surveillance System, 2020-2024[J]. Chin J Infect Control, 2025,24(12):1735-1745. DOI:10.12138/j. issn.1671-9638.20255417.

复制
分享
文章指标
  • 摘要阅读次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:2025-10-05
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2025-12-31
  • 出版日期: 2025-12-28